Hamlet BioPharma Participates in The Global Forum 2024
Hamlet BioPharma, the pharmaceutical company, specializing in the development of drugs for cancer and infections, announce its participation in The Global Forum 2024 By BioStock, set to take place in Lund, Sweden, on May 29-30, 2024. The company will present at 3 pm on Thursday the 30th of May.
The Global Forum 2024 by BioStock is a premier international event in the life science industry, bringing together industry leaders, researchers, investors, and entrepreneurs to discuss the latest advancements and innovations in biotechnology and medical research. The forum provides a unique platform for networking, knowledge exchange, and business development, with a focus on promoting global collaboration and investment in future medical solutions. Hamlet BioPharma is proud to participate in this prestigious event and looks forward to contributing to the important discussions and opportunities that The Global Forum 2024 offers.
For more information about The Global Forum 2024 By BioStock, please visit The Global Forum 2024 web page.
For further information, please contact:
Catharina Svanborg, Chairman and Founder of Hamlet BioPharma, +46-709 42 65 49
catharina.svanborg@hamletpharma.com
Martin Erixon, CEO Hamlet BioPharma, +46-733 00 43 77